E&G ADVISORS, LP – Bristol-Myers Squibb Company Transaction History
E&G ADVISORS, LP portfolio value:
$398,000
portfolio value
E&G ADVISORS, LP quarter portfolio value change:
-7.68%
quarter
Bristol-Myers Squibb Company 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -1.23% | -70 shares | -39K | $71.09 | 5.6K |
Q2 2022 | share | Decrease | -0.53% | -30 shares | 21K | $77 | 5.67K |
Q1 2022 | share | Decrease | -12.31% | -800 shares | 11K | $73.03 | 5.7K |
Q4 2021 | share | 0.00% | 0 shares | 20K | $62.52 | 6.5K | |
Q3 2021 | share | Decrease | -2.99% | -200 shares | -38K | $59.17 | 6.5K |
Q1 2021 | share | 0.00% | 0 shares | 7K | $62.15 | 6.7K | |
Q4 2020 | share | 0.00% | 0 shares | 12K | $60.6 | 6.7K | |
Q3 2020 | share | 0.00% | 0 shares | 10K | $58 | 6.7K | |
Q2 2020 | share | 0.00% | 0 shares | 21K | $56.14 | 6.7K | |
Q1 2020 | share | Increase | +13.56% | 800 shares | -6K | $52.79 | 6.7K |
Q4 2019 | share | Decrease | -25.32% | -2K shares | -22K | $60.36 | 5.9K |
Q3 2019 | share | Decrease | -2.47% | -200 shares | 34K | $47.3 | 7.9K |
Q2 2019 | share | Increase | +8.00% | 600 shares | 9K | $41.93 | 8.1K |
Q1 2019 | share | Decrease | -30.56% | -3.3K shares | -203K | $43.73 | 7.5K |
Q4 2018 | share | Increase | +11.34% | 1.1K shares | -41K | $47.21 | 10.8K |
Q3 2018 | share | Increase | +24.36% | 1.9K shares | 170K | $56.02 | 9.7K |
Q2 2018 | share | Increase | +9.86% | 700 shares | -17K | $49.59 | 7.8K |
Q1 2018 | share | Decrease | -9.16% | -716 shares | -30K | $56.31 | 7.1K |
Q4 2017 | share | Increase | +23.75% | 1.5K shares | 76K | $54.21 | 7.81K |
Q3 2017 | share | Increase | +23.46% | 1.2K shares | 118K | $56.04 | 6.31K |
Q2 2017 | share | Increase | 0.00% | 5.11K shares | 285K | $48.65 | 5.11K |
Q2 2016 | share | Decrease | -100.00% | -3.81K shares | -244K | $62.9 | 0 |
Q1 2016 | share | 0.00% | 0 shares | -19K | $54.35 | 3.81K |